Skip to main content
. 2023 Jul 28;5(30):664–671. doi: 10.46234/ccdcw2023.129

Table S2. Evolution of drug resistance mutations in Chinese individuals with HIV who are naïve to antiretroviral therapy, categorized by stages of NFATP development, from 2004 to 2022.

Drug resistance mutation 2004–2007
( n =1,251)
2008–2011
( n =8,794)
2012–2015
( n =21,467)
2016–2019
( n =21,391)
2020–2022
( n =4,999)
P * Total
( n =57,902)
N %§ N % N % N % N % N %
Abbreviation: ART=antiretroviral therapy; HIV=human immunodeficiency virus; NFATP=National Free Antiretroviral Treatment Program; NNRTI=non-nucleoside reverse transcriptase inhibitor; EFV=efavirenz; NVP=nevirapine; NRTI=nucleoside reverse transcriptase inhibitor; (any: ABC=abacavir; AZT=azidothymidine; d4T=stavudine; DDI=didanosine; FTC=emtricitabine; 3TC=lamivudine; TDF=tenofovir); PI=protease inhibitor; ATV/r=atazanavir/ritonavir; DRV/r=darunavir/ritonavir; LPV/r=lopinavir/ritonavir.
* P values were calculated using Cochran-Armitage trend test. P values <0.05 is statistically significant.
Number of drug resistance amongst ART-naïve individuals infected with HIV surveyed.
§ Prevalence of ART-naïve individuals infected with HIV that exhibit drug resistance.
Total 32 2.6 283 3.2 740 3.4 953 4.5 392 7.8 <0.001 2,400 4.1
NNRTI (EFV, NVP) 23 1.8 177 2 479 2.2 708 3.3 336 6.7 <0.001 1,723 3.0
A98G 2 0.2 17 0.2 16 0.1 30 0.1 22 0.4 0.007 87 0.2
L100I 1 0.1 2 0 5 0 7 0 4 0.1 0.268 19 0
K101E/P/H 1 0.1 17 0.2 41 0.2 45 0.2 22 0.4 0.010 126 0.2
K103S/T/N 5 0.4 41 0.5 119 0.6 216 1 172 3.4 <0.001 553 1.0
V106I/M/A 4 0.3 24 0.3 66 0.3 97 0.5 32 0.6 <0.001 223 0.4
V108I 5 0.4 26 0.3 52 0.2 37 0.2 14 0.3 0.097 134 0.2
E138A/G/K/Q 1 0.1 11 0.1 96 0.4 141 0.7 39 0.8 <0.001 288 0.5
V179D/E/L/T 4 0.3 35 0.4 165 0.8 243 1.1 84 1.7 <0.001 531 0.9
Y181C/I 7 0.6 27 0.3 56 0.3 60 0.3 21 0.4 0.889 171 0.3
Y188C/F/L 0 0 14 0.2 13 0.1 22 0.1 9 0.2 0.398 58 0.1
G190A/C/E/S 3 0.2 22 0.3 52 0.2 69 0.3 25 0.5 0.008 171 0.3
H221Y 1 0.1 10 0.1 23 0.1 39 0.2 7 0.1 0.105 80 0.1
P225H 1 0.1 2 0 7 0 13 0.1 16 0.3 <0.001 39 0.1
F227C/I/L 2 0.2 4 0 14 0.1 15 0.1 1 0 0.523 36 0.1
M230I/L 2 0.2 4 0 7 0 22 0.1 2 0 0.352 37 0.1
L234I 0 0 0 0 1 0 1 0 0 0 0.813 2 0
K238N/T 0 0 2 0 7 0 13 0.1 7 0.1 0.002 29 0.1
NRTI (any) 13 1 117 1.3 276 1.3 293 1.4 76 1.5 0.190 775 1.3
M41L 2 0.2 13 0.1 32 0.1 22 0.1 5 0.1 0.173 74 0.1
E44A/D 0 0 3 0 1 0 0 0 0 0 0.016 4 0
A62V 2 0.2 4 0 9 0 4 0 2 0 0.081 21 0
K65R 2 0.2 14 0.2 19 0.1 44 0.2 8 0.2 0.165 87 0.2
D67N 2 0.2 15 0.2 34 0.2 41 0.2 11 0.2 0.372 103 0.2
S68G 1 0.1 10 0.1 23 0.1 29 0.1 1 0 0.660 64 0.1
T69D/N 4 0.3 7 0.1 16 0.1 12 0.1 6 0.1 0.280 45 0.1
K70E/T/R/ 2 0.2 14 0.2 35 0.2 48 0.2 7 0.1 0.442 106 0.2
L74F/I 0 0 2 0 14 0.1 19 0.1 5 0.1 0.023 40 0.1
V75A/M/I 1 0.1 14 0.2 13 0.1 19 0.1 2 0 0.117 49 0.1
F77L 1 0.1 1 0 0 0 1 0 1 0 0.447 4 0
Y115F 0 0 1 0 3 0 8 0 1 0 0.172 13 0
F116Y 1 0.1 2 0 0 0 0 0 0 0 0.001 3 0
Q151M/L 1 0.1 5 0.1 1 0 1 0 0 0 0.001 8 0
M184I/V 3 0.2 29 0.3 85 0.4 82 0.4 33 0.7 0.019 232 0.4
L210W 1 0.1 15 0.2 41 0.2 23 0.1 4 0.1 0.070 84 0.1
T215F/Y 2 0.2 36 0.4 67 0.3 61 0.3 15 0.3 0.335 181 0.3
K219E/N 3 0.2 11 0.1 6 0 15 0.1 3 0.1 0.102 38 0.1
PI (ATV/r, DRV/r, LPV/r) 2 0.2 25 0.3 56 0.3 39 0.2 9 0.2 0.094 131 0.2
L10F 0 0 1 0 1 0 1 0 1 0 0.737 4 0
K20T 0 0 0 0 1 0 2 0 0 0 0.544 3 0
L24I 0 0 0 0 0 0 0 0 1 0 0.070 1 0
V32I 0 0 1 0 6 0 1 0 0 0 0.282 8 0
L33F 0 0 0 0 1 0 3 0 1 0 0.110 5 0
K43T 0 0 1 0 0 0 0 0 1 0 0.813 2 0
M46I/L 0 0 3 0 10 0 4 0 0 0 0.193 17 0
I47V 0 0 3 0 10 0 5 0 0 0 0.273 18 0
G48R 0 0 0 0 4 0 1 0 0 0 0.719 5 0
I50V/L 1 0.1 3 0 4 0 4 0 1 0 0.286 13 0
F53L 0 0 0 0 4 0 1 0 0 0 0.719 5 0
I54M/V 0 0 3 0 9 0 5 0 2 0 0.881 19 0
Q58E 0 0 0 0 1 0 3 0 0 0 0.377 4 0
G73R/V 0 0 0 0 2 0 3 0 0 0 0.535 5 0
L76V 0 0 0 0 3 0 5 0 0 0 0.389 8 0
V82A/F 1 0.1 5 0.1 14 0.1 8 0 2 0 0.279 30 0.1
I84L/V 0 0 2 0 4 0 4 0 0 0 0.610 10 0
N88S/T 0 0 0 0 5 0 4 0 1 0 0.381 10 0
L89T 0 0 1 0 0 0 0 0 0 0 0.140 1 0
L90M 0 0 10 0.1 9 0 5 0 4 0.1 0.164 28 0